Peter

Director @ | past @Apple @AKQA @TBWAChiatLA @Google @RGA

[Peter @westniles]

I find it deeply unethical and disturbing that the FDA has not approved Capricor Therapeutics' Dermiocel for DMD and BMD patients yet. The science was there years ago. For these boys, time is muscle. The FDA has acknowledged this as well, but yet no action besides a distant date of potential consideration.

[Peter @westniles]

@MSBIntel Near should have dwarfed Solana from the beginning. They just had a good designer and that's all the web3 token collectors cared about. Near was a superior technology all a long.

[Peter @westniles]

@Gfilche @grok $HUMA

[Peter @westniles]

@elonmusk thought this was a run club for a second

[Peter @westniles]

@AppleHelix Couldn't have said it better myself.

[Peter @westniles]

@calleymeans He may be ok but the fact that he allowed Prasad to run CBER is a complete joke. Glad they both got fired!

[Peter @westniles]

@yoalexrapz @DrMakaryFDA this guy is all talk no walk.

[Peter @westniles]

100%

[Palmer Luckey @PalmerLuckey]

It is time for the United States Postal Service to ban junk mail.

Unsolicited spam calls are already prohibited by the FCC. Emails are heavily regulated by the CAN-SPAM Act of 2003. Junk mail is the majority of mail, 100 million trees per year. Enough!

[Peter @westniles]

@DrMakaryFDA ALL TALK NO WALK

[Peter @westniles]

@ryancohen incredible tweet

[Peter @westniles]

@houmanhemmati @Elijahjstacy The only people who need this reminder are literally those who run the @US_FDA

[Peter @westniles]

@nategeier @openclaw @microchipgnu @surgecodes @PKuveke always ahead of the game @nategeier !!!

[Peter @westniles]

@InternetH0F Who’s making giant robots?

[Peter @westniles]

A lot of humanoid robot brands. Who’s making giant robots like Mechwarriors?

[Tansu Yegen @TansuYegen]

A 5,000 kg giant mechanical hand—built from scratch!
A Chinese creator engineered this massive robotic hand, combining raw power with precision control…

[Peter @westniles]

@brian_armstrong @johnpalmer Sport gambling should not be a part of Coinbase period. If chase pushed this on me I would remove all of my funds immediately

[Tesla @Tesla]

TERAFAB: the next step to becoming a galactic civilization

Together with @SpaceX & @xAI, we're building the largest chip manufacturing facility ever (1TW/year) – combining logic, memory & advanced packaging under one roof.

To harness as much power as possible from the Sun, we need to send 100 million tons of solar capture into space – per year.

This requires massive scale.

– Capability to launch millions of tons of mass into orbit

– Solar-powered AI satellites

– Millions of @Tesla_Optimus robots to help build it out

All of these need chips: 100-200GW of chips for Optimus alone, plus terawatts for solar-powered AI satellites.

That's more than all the chip manufacturers in the world combined can provide today, or even by 2030 (based on projected production growth).

We're building TERAFAB to close the gap between today’s chip production & the future's demand – a future among the stars

https://t.co/tHumlppgMm

[Peter @westniles]

@US_FDA Hoping for someone who has experience adjudicating living-saving drugs and therapies. Prasad had zero experience.

[Peter @westniles]

@US_FDA Anyone else triggered by this?

[Peter @westniles]

@DrMakaryFDA Dude I could name 10 biotechs you are intentionally slow rolling right now. How do you sleep at night?

[Anish Moonka @anishmoonka]

Brian sold 2% of his Coinbase stake, about $110 million, to co-found a company called NewLimit in 2021. Its mission is to reprogram old human cells back to younger states.

So when he tweets that aging is a “disease,” he’s not making a philosophical argument. He’s talking about a market he’s personally betting nine figures on.

About 150,000 people die every day worldwide, and roughly two-thirds of those deaths are age-related. Heart disease, cancer, stroke, dementia, all conditions where age is the single biggest risk factor.

NewLimit has raised about $250 million total. Kleiner Perkins led a $130 million round in May 2025. Then in October, Eli Lilly put in $45 million, pushing the valuation to $1.6 billion. What the company actually does: it uses AI models and lab experiments in a cycle to discover drugs that reprogram liver cells to behave like younger versions of themselves. Three prototype medicines so far. No human trials yet.

Armstrong isn’t alone. Sam Altman put $180 million of his own money into Retro Biosciences, which is raising $1 billion at a $5 billion valuation with no clinical results to show yet. Jeff Bezos was among the early backers of Altos Labs, which launched with $3 billion in 2022. Add NewLimit’s $250 million and the total capital flowing into just these three longevity startups tops $4 billion.

Longevity funding hit $8.5 billion across 331 deals in 2024, more than double the year before. By late 2025, half of all that money was going to cellular reprogramming (turning old cells young again), the same approach NewLimit and Retro both use.

The catch: the FDA doesn’t classify aging as a disease. The WHO almost did but reversed course in 2022. So none of these companies can run trials targeting “aging” directly. They target Alzheimer’s, liver disease, immune decline, and hope the anti-aging effects follow. The track record so far is rough. AbbVie walked away from a $1.5 billion decade-long partnership with Google’s longevity arm Calico late last year. Unity Biotechnology once had a $700 million valuation, then dissolved entirely last year.

When a CEO says aging “will be optional,” check where his money is. Armstrong’s is exactly where his tweet is.